| |
| |
|
| Insider
Information: |
Traber Peter G |
| Relationship: |
Chief Medical Officer |
| City: |
Houston |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
708,349 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$649,872 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
708,349 |
|
|
| Total
Value |
$649,872 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
3
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
5
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -25.1%
|
-155.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
President & CEO |
2018-06-13 |
107,333 |
2009-02-13 |
0 |
Premium* |
|
|
Lisata Therapeutics Ord Shs |
LSTA |
Director |
2022-01-10 |
149,190 |
2015-06-02 |
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
Chief Medical Officer |
2023-09-25 |
451,826 |
2020-12-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2023-09-25 |
4 |
S |
$1.06 |
$747 |
D/D |
(705) |
451,826 |
0 |
% |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2023-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
457,765 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Director |
– • – |
2022-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
65,430 |
149,190 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2022-01-05 |
4 |
S |
$3.09 |
$9,955 |
D/D |
(3,226) |
251,355 |
0 |
% |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
90,200 |
254,581 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-12-10 |
4 |
S |
$2.99 |
$12,196 |
D/D |
(4,083) |
164,381 |
0 |
% |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
13,750 |
168,464 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-10-13 |
4 |
S |
$4.39 |
$15,962 |
D/D |
(3,636) |
154,714 |
0 |
% |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,750 |
158,350 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
9,100 |
144,600 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-05-26 |
4 |
B |
$3.99 |
$79,850 |
D/D |
20,000 |
135,500 |
2.74 |
% |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-05-25 |
4 |
B |
$3.48 |
$17,400 |
D/D |
5,000 |
115,500 |
2.74 |
% |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-05-24 |
4 |
B |
$3.32 |
$41,498 |
D/D |
12,500 |
110,500 |
2.74 |
% |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-03-18 |
4 |
B |
$4.50 |
$45,000 |
D/D |
10,000 |
98,000 |
2.74 |
% |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-03-17 |
4 |
B |
$4.53 |
$45,295 |
D/D |
10,000 |
88,000 |
2.74 |
% |
|
| LSTA |
Lisata Therapeutics Ord S... |
Director |
– • – |
2021-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
37,735 |
83,760 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
38,000 |
78,000 |
0 |
- |
|
| SELB |
Selecta Biosciences Inc |
Chief Medical Officer |
• – – |
2020-12-14 |
4 |
B |
$3.24 |
$129,424 |
D/D |
40,000 |
40,000 |
2.74 |
% |
|
| LSTA |
Lisata Therapeutics Ord S... |
Director |
– • – |
2020-01-13 |
4 |
A |
$3.28 |
$59,998 |
D/D |
18,292 |
46,025 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Director |
– • – |
2019-01-14 |
4 |
A |
$4.95 |
$59,999 |
D/D |
12,121 |
27,733 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Director |
– • – |
2019-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,747 |
15,612 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President & CEO |
• – – |
2018-06-13 |
4 |
AS |
$7.51 |
$751,000 |
D/D |
(100,000) |
107,333 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President & CEO |
• – – |
2018-06-13 |
4 |
OE |
$0.87 |
$87,000 |
D/D |
100,000 |
207,333 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President & CEO |
• – – |
2018-06-08 |
4 |
AS |
$5.86 |
$409,997 |
D/D |
(70,000) |
107,333 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President & CEO |
• – – |
2018-06-08 |
4 |
OE |
$0.87 |
$60,900 |
D/D |
70,000 |
177,333 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
